Chronic everolimus treatment of high‐fat diet mice leads to a reduction in obesity but impaired glucose tolerance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronic everolimus treatment of high‐fat diet mice leads to a reduction in obesity but impaired glucose tolerance

Published:2021-03-14 Issue:2 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Chang Geng‐Ruei¹^ORCID,Hou Po‐Hsun²³,Wang Chao‐Min¹,Wu Ching‐Feng⁴,Su Huang‐Kai¹,Liao Huei‐Jyuan¹,Chen To‐Pang⁵

Affiliation:

1. Department of Veterinary Medicine National Chiayi University Chiayi Taiwan

2. Department of Psychiatry Taichung Veterans General Hospital Taichung Taiwan

3. Faculty of Medicine National Yang‐Ming University Taipei Taiwan

4. Division of Thoracic and Cardiovascular Surgery Department of Surgery Chang Gung UniversityChang Gung Memorial Hospital Taoyuan Taiwan

5. Division of Endocrinology and Metabolism Show Chwan Memorial Hospital Changhua Taiwan

Funder

Chang Gung Memorial Hospital, Linkou

National Chung-Hsing University

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.732

Reference57 articles.

1. The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study

2. Assessment of the Role of Everolimus Therapy in Patients with Renal Cell Carcinoma Based on Daily Routine and Recent Research Results

3. Everolimus is a new anti-cancer molecule: Metabolic side effects as lipid disorders and hyperglycemia

4. Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer

5. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives;Seminars in Cancer Biology;2024-02

2. Pharmacological effects of mTORC1/C2 inhibitor in a preclinical model of NASH progression;Biomedicine & Pharmacotherapy;2023-11

3. Prenatal Exposition to Different Immunosuppressive Protocols Results in Vacuolar Degeneration of Hepatocytes;Biology;2023-04-26

4. Implications of cancer stem cells in diabetes and pancreatic cancer;Life Sciences;2023-01

5. The Effect of Dietary Fat and Sucrose on Cognitive Functioning in Mice Lacking Insulin Signaling in Neuropeptide Y Neurons;Frontiers in Physiology;2022-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3